Welcome to a 2-part series in which we identify and distill some key learnings for partnering success in today's life sciences sector.

Perhaps one of the most valuable take-aways from the COVID-19 pandemic response is the sheer scale of what may be achieved through effective collaboration. Over the next three episodes, we'll talk to a range of different stakeholders from across BioInsights' fields of focus, asking them to pass on their tips for what works and what doesn't in this crucial aspect. 

Abi Pinchbeck, Assistant Editor, Immuno-oncology Insights, speaks to Arjun Goyal

In PART 2,  Arjun Goyal, co-founder and managing director of US-based life sciences venture capital firm Vida Ventures, provides a venture capitalist's perspective on licensing and partnering within immuno-oncology.